Correction to: Inflammopharmacology (2020) 28:1153–1161 https://doi.org/10.1007/s10787-020-00744-0

Unfortunately, abbreviation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the abstract and at the multiple places in the review article is written wrong i.e., SARC-CoV-2. It should be read as SARS-CoV-2. Moreover, COVID-19 should be read as Coronavirus disease 2019.